Second tranche of Lyons Magnus products recalled after FDA investigation
date:Aug 16, 2022
tter has not been found in the products but makes no mention of the former

Root cause analysis indicates that the products did not meet commercial sterility specifications.

While infection related to Cronobacter sakazakii is rare, the common symptoms of illness could include fever, vomiting and urinary tract infection. However, vulnerable and immunocompromised populations may be more susceptible to infection, the FDA notes.

On the other hand, the FDA stresses that Clostridium botulinum may le
3/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/02 09:34